SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001628280-23-005045
Filing Date
2023-02-24
Accepted
2023-02-24 16:01:40
Documents
2
Group Members
BIODISCOVERY 6 FPCILAURENT TOURTOISRAPHAEL WISNIEWSKI

Document Format Files

Seq Description Document Type Size
1 SC 13G mineralys-schedule13g.htm SC 13G 101622
2 EX-99 exhibit99-schedule13g.htm EX-99 7740
  Complete submission text file 0001628280-23-005045.txt   110948
Mailing Address 374 RUE SAINT ST HONORE PARIS I0 75001
Business Address 374 RUE SAINT ST HONORE PARIS I0 75001 33-1-85-73-6603
Andera Partners (Filed by) CIK: 0001757283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Subject) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94000 | Film No.: 23666883
SIC: 2834 Pharmaceutical Preparations